Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma

We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Rare Tumors
Asıl Yazarlar: Attia, Steven, Okuno, Scott H., Robinson, Steven I., Webber, Nicholas P., Indelicato, Daniel J., Jones, Robin L., Bagaria, Sanjay P., Sherman, Courtney, Kozak, Kevin R., Cortese, Cherise M., McFarland, Thomas, Trent, Jonathan C., Maki, Robert G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: PAGEPress Publications, Pavia, Italy 2015
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508650/
https://ncbi.nlm.nih.gov/pubmed/26266019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2015.5992
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller